Detalles de la búsqueda
1.
Budget impact model of Mydrane®, a new intracameral injectable used for intra-operative mydriasis, from a UK hospital perspective.
BMC Ophthalmol
; 18(1): 104, 2018 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-29673317
2.
Assessing the validity of a rapid review against a systematic literature review. A comparison of systematic literature reviews done by Cochrane with rapid reviews and the impact on meta-analyses results.
J Epidemiol Popul Health
; 72(4): 202526, 2024 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38815496
3.
Cost-Effectiveness Analysis of Innovative Therapies for Patients with Non-Alcoholic Fatty Liver Disease.
J Mark Access Health Policy
; 12(2): 35-57, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38660414
4.
A clinical research practice datalink analysis of antidepressant treatment patterns and health care costs in generalized anxiety disorder.
Value Health
; 16(8): 1133-9, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24326166
5.
Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and Z-drugs consumption in nine European countries.
Eur J Clin Pharmacol
; 69(4): 1-10, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23114457
6.
Impact of therapy escalation on ambulatory care costs among patients with type 2 diabetes in France.
BMC Endocr Disord
; 13: 15, 2013 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-23627403
7.
Further evidence of reliability and validity of the Huntington's disease quality of life battery for carers: Italian and French translations.
Qual Life Res
; 22(5): 1093-8, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22821667
8.
Systematic literature reviews over the years.
J Mark Access Health Policy
; 11(1): 2244305, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37614556
9.
Rapid literature review: definition and methodology.
J Mark Access Health Policy
; 11(1): 2241234, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37533549
10.
Economic evaluation of encorafenib with cetuximab in patients with BRAF V600E-mutant metastatic colorectal cancer in France: a cost-effectiveness analysis using data from the BEACON CRC randomised controlled trial.
BMJ Open
; 12(11): e063700, 2022 11 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36410812
11.
Considering potential solutions for limitations and challenges in the health economic evaluation of gene therapies.
Expert Rev Pharmacoecon Outcomes Res
; 21(6): 1145-1158, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34407704
12.
An overview of health technology assessments of gene therapies with the focus on cost-effectiveness models.
J Mark Access Health Policy
; 9(1): 2002006, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34790341
13.
Allocating treatment resources for hepatitis C in the UK: a constrained optimization modelling approach.
J Mark Access Health Policy
; 9(1): 1887664, 2021 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33828822
14.
Efficacy and Safety of Rivaroxaban Compared with Other Therapies Used in Patients with Peripheral Artery Disease Undergoing Peripheral Revascularization: A Systematic Literature Review and Network Meta-Analysis.
Cardiovasc Ther
; 2021: 8561350, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34497668
15.
Real-world cost-effectiveness of rivaroxaban compared with vitamin K antagonists in the context of stroke prevention in atrial fibrillation in France.
PLoS One
; 15(1): e0225301, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31978044
16.
Economic burden for Alzheimer's disease in China from 2010 to 2050: a modelling study.
J Mark Access Health Policy
; 7(1): 1667195, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31595183
17.
Cost-effectiveness of pirfenidone compared to all available strategies for the treatment of idiopathic pulmonary fibrosis in France.
J Mark Access Health Policy
; 7(1): 1626171, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31275535
18.
Cost-effectiveness analyses using real-world data: an overview of the literature.
J Med Econ
; 22(6): 545-553, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30816067
19.
Cost-effectiveness analysis of pembrolizumab versus standard-of-care chemotherapy for first-line treatment of PD-L1 positive (>50%) metastatic squamous and non-squamous non-small cell lung cancer in France.
Lung Cancer
; 127: 44-52, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30642550
20.
Health related quality of life in patients having schizophrenia negative symptoms - a systematic review.
J Mark Access Health Policy
; 6(1): 1517573, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30275939